# DESCRIPTION

## BACKGROUND OF THE INVENTION

- introduce radiology and organic chemistry
- describe molecular imaging techniques
- highlight limitations of current techniques

## SUMMARY OF THE INVENTION

- introduce hydrophilic, nonionic, fluorinated probes
- describe liposome nanoparticle formulation
- highlight multiple probes with distinct 19F MRI signatures
- introduce nonionic 19F-MR contrast molecules
- describe formula Xâ€”(R)n
- highlight magnetically equivalent fluorine atoms
- describe vicinal diol group
- introduce saccharide moiety
- highlight glucose moiety
- describe non-dendrimeric molecules
- highlight molecular weight
- describe water solubility
- highlight hydrophilic character
- describe n-octanol/water partition coefficient
- highlight polar surface area

## DETAILED DESCRIPTION OF THE INVENTION

- introduce novel 19F-MR contrast molecules

### I. Definitions

- define hydrogen and other chemical groups
- define bond symbols
- explain ring atom notation
- define implicit hydrogen atoms
- explain floating groups on ring systems
- define numeric variables for replaceable hydrogens
- explain parenthetical subscripts for groups and classes
- define saturated compounds
- define aliphatic compounds
- define alkyl, alkanediyl, and alkylidene groups
- define alkenyl, alkenediyl, and alkynyl groups
- define aryl and arenediyl groups
- define aralkyl
- define heteroaryl
- define heteroarenediyl
- define heterocycloalkyl
- define acyl
- define alkoxy
- define alkoxydiyl
- define alkylthio
- define acylthio
- define alcohol
- define alkylamino
- define dialkylamino
- define chiral auxiliary
- define various terms

### II. Formulations and Routes of Administration

- formulate diagnostic compositions
- combine with excipients for administration
- describe pharmaceutical operations
- administer by various methods
- coat compositions for protection
- administer by parenteral routes
- prepare injectable solutions and dispersions
- formulate oral compositions
- determine dosage amounts
- adjust dosage based on factors

### III. 19F MR Contrast Molecules

- synthesize 19F MR contrast molecules

## EXAMPLES

- introduce molecular imaging probes
- motivate development of 19F MRI probes
- describe limitations of current probes
- introduce disclosed probes as solution

### Example 1

- describe materials and methods

### Example 2

- describe chemical synthesis procedure for compound 1

### Example 3

- describe procedure for compound 2

### Example 4

- describe procedure for compound 3

### Example 5

- describe procedure for compound 4

### Example 6

- describe procedure for compound 6

### Example 7

- describe procedure for compound 8

### Example 8

- describe procedure for compound 9

### Example 9

- prepare compound 10
- synthesize compound 11
- synthesize compound 12
- synthesize compound 13
- synthesize compound 14
- synthesize compound 15
- synthesize compound 16
- prepare ET0863
- prepare ET0876 and ET0886
- describe synthesis of ET0890
- describe preparation of 19F liposomes
- describe MRI acquisition and data processing
- describe results of MRI scans on phantoms
- describe in vivo evaluation of probes in mice
- describe synthesis of ET1084
- describe synthesis of compound 17
- describe synthesis of compound 18
- describe synthesis of compound 19
- describe synthesis of compound 20
- describe final step to ET1084
- describe 19F-MR phantom images using ET1084
- describe 19F MRI phantom images
- describe graph of contrast-to-noise ratio
- describe 19F NMR spectrum of ET1084
- conclude examples

